Cargando…
A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer
Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location. In addition, following initial curative therapy, many patients present with limited...
Autores principales: | Patel, Pretesh R., Yoo, David S., Niibe, Yuzuru, Urbanic, James J., Salama, Joseph K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483729/ https://www.ncbi.nlm.nih.gov/pubmed/23125927 http://dx.doi.org/10.1155/2012/480961 |
Ejemplares similares
-
Oligometastases/Oligo-Recurrence of Lung Cancer
por: Niibe, Yuzuru, et al.
Publicado: (2013) -
Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
por: Gomez, Daniel R., et al.
Publicado: (2012) -
Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy
por: Niibe, Yuzuru, et al.
Publicado: (2010) -
Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature
por: Niibe, Yuzuru, et al.
Publicado: (2012) -
Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)